Xponance, Inc. Royalty Pharma PLC Transaction History

Xponance, Inc.

$10.7 Billion
Q4 2024

A detailed history of Xponance, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Xponance, Inc. holds 38,696 shares of RPRX stock, worth $1.26 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

38,696

Previous 33,294 16.23%

Holding current value

$1.26 Million

Previous $941,000 4.89%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$24.28 - $28.39 $131,160 - $153,362	5,402 Added 16.23%	38,696 $987,000
Q3 2024 Nov 12, 2024	BUY	$25.63 - $29.27 $40,751 - $46,539	1,590 Added 5.02%	33,294 $941,000
Q2 2024 Aug 14, 2024	BUY	$26.26 - $29.9 $15,913 - $18,119	606 Added 1.95%	31,704 $836,000
Q1 2024 May 13, 2024	BUY	$27.46 - $31.33 $482,829 - $550,875	17,583 Added 130.1%	31,098 $944,000
Q4 2023 Jan 31, 2024	SELL	$26.21 - $29.22 $123,265 - $137,421	-4,703 Reduced 25.82%	13,515 $379,000
Q3 2023 Oct 23, 2023	BUY	$26.26 - $31.38 $133,663 - $159,724	5,090 Added 38.77%	18,218 $494,000
Q2 2023 Jul 13, 2023	SELL	$29.6 - $36.56 $444 - $548	-15 Reduced 0.11%	13,128 $403,000
Q1 2023 Apr 17, 2023	BUY	$32.77 - $39.4 $2,064 - $2,482	63 Added 0.48%	13,143 $473,000
Q4 2022 Jan 23, 2023	BUY	$39.17 - $44.04 $233,923 - $263,006	5,972 Added 84.02%	13,080 $0
Q3 2022 Oct 24, 2022	BUY	$39.88 - $44.65 $6,101 - $6,831	153 Added 2.2%	7,108 $286,000
Q2 2022 Aug 02, 2022	SELL	$37.53 - $44.22 $617,068 - $727,065	-16,442 Reduced 70.27%	6,955 $292,000
Q1 2022 Apr 20, 2022	BUY	$37.46 - $42.44 $8,316 - $9,421	222 Added 0.96%	23,397 $912,000
Q4 2021 Jan 31, 2022	BUY	$35.17 - $42.48 $13,399 - $16,184	381 Added 1.67%	23,175 $924,000
Q3 2021 Nov 05, 2021	SELL	$36.14 - $42.24 $49,800 - $58,206	-1,378 Reduced 5.7%	22,794 $824,000
Q2 2021 Aug 12, 2021	BUY	$39.85 - $46.63 $390,251 - $456,647	9,793 Added 68.11%	24,172 $991,000
Q1 2021 May 10, 2021	BUY	$42.34 - $52.82 $408,157 - $509,184	9,640 Added 203.42%	14,379 $627,000
Q4 2020 Feb 11, 2021	BUY	$36.12 - $50.05 $171,172 - $237,186	4,739 New	4,739 $237,000

Others Institutions Holding RPRX

# of Institutions

424

Shares Held

285M

Call Options Held

566K

Put Options Held

36.2K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account